CannAssist International Corp. (CNSC) Engages Communications Industry Leader IBN to Share Story, Reach Millions
- CNSC partners with InvestorBrandNetwork to maximize communication, refine messaging and outreach.
- CannAssist focused on marketing Xceptol consumer brand, which provides products featuring proprietary CiBiDinol technology.
- IBN brings 15-plus years of experience assisting more than 500 client partners improve communications within investment community.
Recognizing the critical nature of communications to the success of a business, CannAssist International (OTCQB: CNSC) has selected to partner with InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities (https://nnw.fm/RBtXL). CannAssist, a biotechnological pharmaceutical and wellness company, owns Xceptor Labs, an R&D and raw material manufacturer, which also has its own product line.
“We are pleased to engage IBN to maximize our communication with existing and potential shareholders while refining our overall messaging and outreach,” said CannAssist CEO Mark Palumbo.
Currently, CannAssist is focused on marketing its Xceptol consumer brand, which provides products that feature Xceptor Labs’ proprietary CiBiDinol technology. According to CannAssist, CiBiDinol is a method of creating CBD products that have better absorption than other oil-based products currently available. CiBiDinol provides CBD in a format that is more in line with the body’s natural bioactivity, the company said. Specifically, CiBiDinol is designed to tackle issues with oil-soluble CBD molecules, such as delivery, bioavailability and short shelf-life. CannAssist notes that the product in the brand also offers more predictable potency.
The CannAssist story is certainly one worth telling, and IBN is focused on telling that story through a variety of ways. IBN has built an investor-based distribution network of 5,000-plus key syndication outlets; the company also produces various newsletters and manages a variety of social media platforms, wire service, blogs and other outreach tools. The purpose of the IBN partnership is to generate greater awareness for CannAssist International Corp.
“The cannabidiol market has been on fire since the 2018 Farm Bill was signed into law,” said IBN director of client solutions Chris Johnson. “In 2018, the global CBD market was valued at $4.6 billion, and it’s forecast to reach $23.6 billion by 2025, according to Grand View Research. CannAssist is uniquely positioned to capitalize on this market growth.
“Based on current revenue from raw material sales, retail sales and the Xceptol brand’s international distribution, CannAssist expects to reach first-year sales of $5 million,” Johnson continued. “We’re excited to customize our comprehensive suite of corporate communications solutions for the company as it seeks to expand its product pipeline and achieve steady sales growth in the years ahead.”
Johnson noted that with 15-plus years of experience assisting more than 500 client partners improve communications within the investment community, IBN is the ideal organization to work alongside CannAssist. Through its family of 50-plus trusted brands and millions of social media followers, IBN is uniquely positioned to offer CannAssist the essential expertise, insight and tools to reach a wider audience of investors, consumers and more.
CannAssist, owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company. Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its consumer line of cannabidiol (“CBD”) products under the Xceptol brand.
For more information, visit the company’s website at www.CannAssistInternational.com.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- CNSC partners with InvestorBrandNetwork to maximize communication, refine messaging and outreach.
- CannAssist focused on marketing Xceptol consumer brand, which provides products featuring proprietary CiBiDinol technology.
- IBN brings 15-plus years of experience assisting more than 500 client partners improve communications within investment community.
Recognizing the critical nature of communications to the success of a business, CannAssist International (OTCQB: CNSC) has selected to partner with InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities (https://nnw.fm/RBtXL). CannAssist, a biotechnological pharmaceutical and wellness company, owns Xceptor Labs, an R&D and raw material manufacturer, which also has its own product line.
“We are pleased to engage IBN to maximize our communication with existing and potential shareholders while refining our overall messaging and outreach,” said CannAssist CEO Mark Palumbo.
Currently, CannAssist is focused on marketing its Xceptol consumer brand, which provides products that feature Xceptor Labs’ proprietary CiBiDinol technology. According to CannAssist, CiBiDinol is a method of creating CBD products that have better absorption than other oil-based products currently available. CiBiDinol provides CBD in a format that is more in line with the body’s natural bioactivity, the company said. Specifically, CiBiDinol is designed to tackle issues with oil-soluble CBD molecules, such as delivery, bioavailability and short shelf-life. CannAssist notes that the product in the brand also offers more predictable potency.
The CannAssist story is certainly one worth telling, and IBN is focused on telling that story through a variety of ways. IBN has built an investor-based distribution network of 5,000-plus key syndication outlets; the company also produces various newsletters and manages a variety of social media platforms, wire service, blogs and other outreach tools. The purpose of the IBN partnership is to generate greater awareness for CannAssist International Corp.
“The cannabidiol market has been on fire since the 2018 Farm Bill was signed into law,” said IBN director of client solutions Chris Johnson. “In 2018, the global CBD market was valued at $4.6 billion, and it’s forecast to reach $23.6 billion by 2025, according to Grand View Research. CannAssist is uniquely positioned to capitalize on this market growth.
“Based on current revenue from raw material sales, retail sales and the Xceptol brand’s international distribution, CannAssist expects to reach first-year sales of $5 million,” Johnson continued. “We’re excited to customize our comprehensive suite of corporate communications solutions for the company as it seeks to expand its product pipeline and achieve steady sales growth in the years ahead.”
Johnson noted that with 15-plus years of experience assisting more than 500 client partners improve communications within the investment community, IBN is the ideal organization to work alongside CannAssist. Through its family of 50-plus trusted brands and millions of social media followers, IBN is uniquely positioned to offer CannAssist the essential expertise, insight and tools to reach a wider audience of investors, consumers and more.
CannAssist, owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company. Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its consumer line of cannabidiol (“CBD”) products under the Xceptol brand.
For more information, visit the company’s website at www.CannAssistInternational.com.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
